Patients were included in an analysis of mean change from preoperative to postoperative assessment of the number of items missed on the SPMSQ using analysis of covariance (ANCOVA) model which contained baseline status as covariate, and the treatment group as the effect of interest.
Ketamine and Changes of the Short Portable Mental Status Questionnaire
Brief Summary
Intervention / Treatment
-
Ketamine (DRUG)Ketamine: (dose 0.3 mcg/kg) included in physiological solution at 0.9% (250 ml) during 2 hours, intravenously.
-
physiological solution (DRUG)physiological solution at 0.9% (250 ml) during 2 hours, intravenously, with the same physical characteristics of ketamine.
Condition or Disease
- Postoperative Cognitive Dysfunction
Phase
Study Design
Study type: | INTERVENTIONAL |
---|---|
Status: | Completed |
Study results: | No Results Available |
Age: | 60 Years to 85 Years |
Enrollment: | 80 (ACTUAL) |
Funded by: | Other |
Allocation: | Randomized |
Primary Purpose: | Supportive Care |
MaskingQUADRUPLE:
|
Clinical Trial Dates
Start date: | Jun 01, 2013 | |
---|---|---|
Primary Completion: | Jan 01, 2014 | ACTUAL |
Completion Date: | May 01, 2014 | ACTUAL |
Study First Posted: | Jan 30, 2014 | ESTIMATED |
Results First Posted: | Aug 31, 2020 | |
Last Updated: | Nov 23, 2014 |
Sponsors / Collaborators
- Administration of ketamine will be suspended during the study for any cause considered as a risk to the patient according to the judgment of the researchers.
Participant Groups
-
Ketamine: (dose 0.3 mcg/kg) included in physiological solution at 0.9% (250 ml) during 2 hours, intravenously.
-
Control group: only physiological solution at 0.9% (250 ml) during 2 hours, intravenously.
Eligibility Criteria
Sex: | All |
---|---|
Minimum Age: | 60 |
Maximum Age: | 85 |
Age Groups: | Adult / Older Adult |
Healthy Volunteers: | Yes |
* Patients be over 60 years and older.
* Intraocular pressure less than 20 millimeter of mercury.
* American Society of Anaesthesiologists (ASA) physical status classification, I-III.
Exclusion Criteria:
* History of psychosis or schizophrenia.
* Nephropathy.
* Difficult to control hypertension.
* Uncontrolled hepatic disorders.
* Allergy to ketamine.
* Moderate to severe depression.
* Post-operative delirium.
* Needed to use medications other than those contemplated in the study.
Primary Outcomes
Secondary Outcomes
-
Analysis of changes over time in hemodynamic parameters was done during the surgery
-
Analysis of changes over time in respiratory rate was done during the surgery with a general lineal model.
-
Analysis of changes over time in oxygen saturation measures was done during the surgery with a general lineal model
-
Sedation according to the Ramsey Scale from baseline to the final assessment (90minutes into surgery), was done with a general lineal model.
-
Analysis of change in intraocular pressure over time was done previous retrobulbar block and at the end of surgery with a general lineal model over non-surgical eye.
-
Analgesia was evaluated after regional anesthesia (retrobulbar block) and after surgery, a comparison was made between groups by the Chi-squared test (χ2).
More Details
NCT Number: | NCT02049411 |
---|---|
Acronym: | SPMSQ-E |
Other IDs: | R-2012-3601-56 |
Study URL: | https://clinicaltrials.gov/study/NCT02049411 |